Norway· NO-ID_34369793-35F0-45AD-B026-9D2C0F37DCAE

Mestinon retard

A pyridostigmine product containing pyridostigmine bromide, registered in Norway by Viatris. The same ATC class is registered in 16 of our 19 countries.

ATC N07AA02

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedMestinon retardATCN07AA02REGISTER NO.NO-ID_34369793-35F0-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Pyridostigmine is registered in 16 of 19 countries.

Countries holding a registration under ATC N07AA02 (pyridostigmine), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 8 of them publish a price we can compare per daily dose

Pyridostigmine · ATC N07AA02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pyridostigmine costs, country by country.

Normalised to the WHO defined daily dose (0.18 g), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Pyridostigmine · price per daily dose (0.18 g)

USD · FX 28 Sept 2026

  • CH Switzerland$2.06
  • FR France$1.63
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Pyridostigmine Bromide
Manufacturer
Viatris
Country
Norway (NO)
ATC code
N07AA02
ATC class
Pyridostigmine
Defined daily dose
0.18 g, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

  • no_merkevare_id
    ID_34369793-35F0-45AD-B026-9D2C0F37DCAE
  • no_varenummer
    217367
    100
  • gtin
    4150030434934

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

106 interactions on record for pyridostigmine.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Pyridostigmine · interactions on record

106 records

  • 2 severe
  • 56 moderate
  • 48 info

Most severe, free to view

  • SiponimodL04AA42severe
  • SiponimodL04AE03severe
  • DicycloverineA03AA07moderate
  • PropanthelineA03AB05moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pyridostigmine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pyridostigmine products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Mestinon
  • Belgium · Mestinon
  • Bulgaria · Калимин
  • Czechia · Mestinon
  • Germany · Amindan, Kalymin
  • Denmark · Mestinon, Pyridostigminbromid Orifarm
  • Estonia · Kalymin, Mestinon
  • Spain · Mestinon
  • Finland · Mestinon
  • France · Mestinon, Mestinon Lp
  • United Kingdom (Northern Ireland) · Mestinon, Pyridostigmine Bromide
  • Greece · Mestinon
  • Croatia · Mestinon 60
  • Hungary · Mestinon
  • Ireland · Mestinon
  • Italy · Mestinon
  • Luxembourg · Mestinon
  • Latvia · Kalymin 60 N, Mestinon
  • Malta · Mestinon
  • Netherlands · Mestinon, Mestinon 60
  • Poland · Mestinon, Stygmistanon
  • Portugal · Mestinon
  • Romania · Mestinon
  • Sweden · Mestinon, Pyridostigmin Orifarm
  • Slovenia · Mestinon
  • Slovakia · Mestinon

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/66a1cb47-ceef-4535-80ab-dfdb3d58c25b
GET /v1/drugs/66a1cb47-ceef-4535-80ab-dfdb3d58c25b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Depottablett",
  "source": "fest",
  "status": "A",
  "atc_name": "Pyridostigmin",
  "merkevare_id": "ID_34369793-35F0-45AD-B026-9D2C0F37DCAE",
  "name_form_strength": "Mestinon retard depottab 180 mg",
  "prescription_group": "C"
}

See everything about pyridostigmine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.